Envoy Medical prices $2.5M registered direct offering at $1.31/share, plus warrants for up to $7.5M

Envoy Medical, Inc.

Gross proceeds ~$2.5M from sale of 1,908,402 shares at $1.31/share; close expected Sept 23, 2025.
Concurrent private placement of warrants for 5,725,206 shares at $1.31, exercisable after stockholder approval.
Full warrant exercise could yield additional ~$7.5M in proceeds; warrants expire 24 months after stockholder approval.
Net proceeds for working capital and general corporate purposes.
H.C. Wainwright acts as placement agent; receives 7.5% cash fee and additional warrants.

item 1.01item 3.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.